2021
DOI: 10.1093/ajhp/zxab325
|View full text |Cite
|
Sign up to set email alerts
|

ASHP Guidelines on the Safe Use of Automated Dispensing Cabinets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…ADC overrides should be assessed periodically to prevent misuse. For example, the reason for each ADC override should be documented and the ADC override medication list should be periodically re-examined [27]. These measures require pharmacists and clinical medical staff discussions to determine the specific methods suitable for each hospital.…”
Section: Discussionmentioning
confidence: 99%
“…ADC overrides should be assessed periodically to prevent misuse. For example, the reason for each ADC override should be documented and the ADC override medication list should be periodically re-examined [27]. These measures require pharmacists and clinical medical staff discussions to determine the specific methods suitable for each hospital.…”
Section: Discussionmentioning
confidence: 99%
“…With a range of technologies available including in‐pharmacy robotics, ADCs, unit dose packaging equipment and controlled substances cabinets, there are many options for monitoring and evaluating drug utilisation 69 . Having these technologies as standalone solutions does provide some benefits; however, integration with pharmacy systems and EHRs provides much more comprehensive and accurate data 70 . Visibility on medication usage across organisations can be maximised to improve understanding of drug usage and associated costs 71 .…”
Section: Theme 5 — Funding Modelsmentioning
confidence: 99%
“…69 Having these technologies as standalone solutions does provide some benefits; however, integration with pharmacy systems and EHRs provides much more comprehensive and accurate data. 70 Visibility on medication usage across organisations can be maximised to improve understanding of drug usage and associated costs. 71 Use of these technologies has also been shown to minimise unnecessary stock wastage.…”
Section: Summary Of Findingsmentioning
confidence: 99%
“…Their institution did not require BCMA in the Radiology area. While there are general recommendations that directly address these areas, 22,24,25 TMSBP Best Practice 7 is designed to be very targeted and addresses risks that could persist even after implementing more general safety interventions. It also represents more feasible risk mitigation compared with larger system changes.…”
Section: Benefits Of Disclosurementioning
confidence: 99%